Latest News

Journal Articles

Brain and neurologic

NCRI 2018: Fluorescent marker helps improve accuracy of brain tumor cell removal

Zika vaccine yields promising results for treating glioblastoma

Has the secret of the immortality cancer switch been unlocked?

Breast

NCRI 2018: Women who are ‘larks’ have a lower risk of developing breast cancer, study suggests

ESMO18: New combination therapy for breast cancer may prolong survival

What are the top 5 breast cancer advancements of 2018?

Colorectal

NCRI 2018: Inherited bowel cancer may be preventable by treatment of pre-cancerous stem cells

Data-driven blood test could be a step towards personalized treatment for bowel cancer

Chemicals found in vegetables prevent colon cancer in mice

Endocrine

NICE recommends new first-line treatment Lenvima against advanced liver cancer

NCRI 2018: HiLo trial suggests low risk thyroid cancer patients can receive lower doses of radiation

Blood test could detect kidney cancer up to 5 years earlier

Gastrointestinal

A remarkable insight into the cancer journey of Barbara Moss

Conference Chair highlights: World Congress on Gastrointestinal Cancer

ESMO WCGI: Trifluridine and tipiracil show promise as metastatic gastric cancer treatment in Phase III trial

Genitourinary

Could urine liquid biopsies help monitor bladder cancer treatment?

NICE approves atezolizumab for advanced bladder cancer patients on the NHS

Breakthrough method to diagnose prostate cancer developed

Gynecologic

SOLO-1: practice-changing results for advanced ovarian cancer patients with BRCA mutation

ESMO18: Olaparib maintenance improves progression-free survival in advanced ovarian cancer by 3 years

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Head and neck

KEYNOTE-048: pembrolizumab changes the rules for head and neck cancer patients

Diabetics face a higher risk of mouth cancer, with women more at risk

The importance of a multidisciplinary team in the care of head and neck cancer

Hematologic

Personalized prediction scheme for myeloproliferative neoplasms developed

NHS England strikes deal for ground-breaking CAR-T therapy in a new European first

NICE rejects Kymriah® for adults with lymphoma

Lung

GioTag: results of real-world study of treatment sequencing in EGFR mutation-positive lung cancer

Plinabulin: a novel immuno-oncology agent for the treatment of chemotherapy-induced neutropenia and advanced NSCLC

It’s checkmate for Opdivo small-cell lung cancer trial

Pancreatic

ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer

Prostate

NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability

Court invalidates patent for prostate cancer drug Zytiga®

Circulating tumor cells: researchers develop mechanism for characterizing function

Rare tumors

Promising Phase I trial for anti-HER2 antibody

Osteoblastoma genetic marker shows promise for identifying aggressive tumors

Best of ASCO18: key takeaways & the practice-changing talks

Skin

NCRI 2018: Male melanoma deaths rising, study reports

FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma

NICE approves dabrafenib–trametinib for BRAF+ melanoma